Curanex Pharmaceuticals (CURX) Current Assets (2024 - 2026)

Curanex Pharmaceuticals (CURX) has reported Current Assets for 3 consecutive years, with $4.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 573.8% year-over-year to $4.8 million; the trailing twelve-month figure through Jun 2026 stood at $4.8 million (up 573.8% YoY), and the FY2025 full-year result was $11.2 million, up 2067.74% from the prior year.
• Current Assets retreated to $4.8 million in Q2 2026 per CURX's latest filing, from $11.2 million in the prior quarter.
• Across five years, Current Assets topped out at $14.4 million in Q3 2025 and bottomed at $517935.0 in Q4 2024.
• Historically, Current Assets has averaged $6.3 million across 3 years, with a median of $4.8 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Current Assets jumped 2067.74% in 2025, then jumped 573.8% in 2026.
• Over 3 years, Current Assets stood at $517935.0 in 2024, then surged by 2067.74% to $11.2 million in 2025, then slumped by 57.31% to $4.8 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $4.8 million, $11.2 million, and $14.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.